Keywords:
Thrombocytopenia
1.
Lippi G, Plebani M: EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med 2012;50:1281-1285.
2.
Ozcelik F, Arslan E, Serdar MA, Yiginer O, Oztosun M, Kayadibi H, Kurt I: A useful method for the detection of ethylenediaminetetraacetic acid- and cold agglutinin-dependent pseudothrombocytopenia. Am J Med Sci 2012;344:357-362.
3.
Bizzaro N: EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995;50:103-109.
4.
Wu W, Guo Y, Zhang L, Cui W, Li W, Zhang S: Clinical utility of automated platelet clump count in the screening for ethylene diamine tetraacetic acid-dependent pseudothrombocytopenia. Chin Med J (Engl) 2011;124:3353-3357.
5.
Silvestri F, Virgolini L, Savignano C, Zaja F, Velisig M, Baccarani M: Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia. Vox Sang 1995;68:35-39.
6.
Lau LG, Chng WJ, Liu TC: Transfusion medicine illustrated. Unnecessary transfusions due to pseudothrombocytopenia. Transfusion 2004;44:801.
7.
Zhou X, Wu X, Deng W, Li J, Luo W: Amikacin can be added to blood to reduce the fall in platelet count. Am J Clin Pathol 2011;136:646-652.
8.
Sakurai S, Shiojima I, Tanigawa T, Nakahara K: Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. Br J Haematol 1997;99:817-823.
9.
Chae H, Kim M, Lim J, Oh EJ, Kim Y, Han K: Novel method to dissociate platelet clumps in EDTA-dependent pseudothrombocytopenia based on the pathophysiological mechanism. Clin Chem Lab Med 2012;50:1387-1391.
10.
Schuff-Werner P, Steiner M, Fenger S, Gross HJ, Bierlich A, Dreissiger K, Mannuss S, Siegert G, Bachem M, Kohlschein P: Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt. Br J Haematol 2013;162:684-692.
11.
Cohen AM, Cycowitz Z, Mittelman M, Lewinski UH, Gardyn J: The incidence of pseudothrombocytopenia in automatic blood analyzers. Haematologia (Budap) 2000;30:117-121.
12.
Bartels PC, Schoorl M, Lombarts AJ: Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia. Scand J Clin Lab Invest 1997;57:629-636.
13.
Garcia Suarez J, Calero MA, Ricard MP, Krsnik I, Rus GP, Perera F, Merino JL: EDTA-dependent pseudothrombocytopenia in ambulatory patients: clinical characteristics and role of new automated cell-counting in its detection. Am J Hematol 1992;39:146-148.
14.
Froom P, Barak M: Prevalence and course of pseudothrombocytopenia in outpatients. Clin Chem Lab Med 2011;49:111-114.
15.
Berkman N, Michaeli Y, Or R, Eldor A: EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol 1991;36:195-201.
16.
Maslanka K, Marciniak-Bielak D, Szczepinski A: Pseudothrombocytopenia in blood donors. Vox Sang 2008;95:349.
17.
Sweeney JD, Holme S, Heaton WA, Campbell D, Bowen ML: Pseudothrombocytopenia in plateletpheresis donors. Transfusion 1995;35:46-49.
18.
Bizzaro N, Brandalise M: EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol 1995;103:103-107.
19.
van der Meer W, Allebes W, Simon A, van Berkel Y, de Keijzer MH: Pseudothrombocytopenia: a report of a new method to count platelets in a patient with EDTA- and temperature-independent antibodies of the IgM type. Eur J Haematol 2002;69:243-247.
20.
Isik A, Balcik OS, Akdeniz D, Cipil H, Uysal S, Kosar A: Relationship between some clinical situations, autoantibodies, and pseudothrombocytopenia. Clin Appl Thromb Hemost 2012;18:645-649.
21.
Choe WH, Cho YU, Chae JD, Kim SH: Pseudothrombocytopenia or platelet clumping as a possible cause of low platelet count in patients with viral infection: a case series from single institution focusing on hepatitis A virus infection. Int J Lab Hematol 2013;35:70-76.
22.
Kuang MH, Ouyang WT, Lin JH, Liu WL: Correlation factors of ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in cancer patients (in Chinese). Zhonghua Yi Xue Za Zhi 2010;90:3144-3146.
23.
Gillis S, Eisenberg ME, Shapira MY, Or R: Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation. Isr Med Assoc J 2003;5:671-673.
24.
Alderman M, Aiyer KJ: Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin 2004;20:369-379.
25.
De Luca G, Secco GG, Santagostino M, Venegoni L, Iorio S, Cassetti E, Verdoia M, Coppo L, Di Mario C, Bellomo G, Marino P: Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 2012;22:426-433.
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.